Home/Filings/4/0000899243-22-008698
4//SEC Filing

Nickson Philip 4

Accession 0000899243-22-008698

CIK 0001826457other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 6:43 PM ET

Size

5.4 KB

Accession

0000899243-22-008698

Insider Transaction Report

Form 4
Period: 2022-03-01
Nickson Philip
Chief Business & Legal Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-01+70,60070,600 total
    Exercise: $13.41Exp: 2032-02-29Common Stock (70,600 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Issuer

Monte Rosa Therapeutics, Inc.

CIK 0001826457

Entity typeother

Related Parties

1
  • filerCIK 0001911369

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:43 PM ET
Size
5.4 KB